Dianthus Therapeutics, Inc.’s DNTH share price has surged by 5.61%, which has investors questioning if this is right time to sell.

Volunteers held the first planting of the year in Scranton on Saturday, marking the start of the spring beautification effort.

Dianthus Therapeutics, Inc. (DNTH) shares soared 6.1% in the last trading session to close at $17.86. The move was backed by solid volume with far more shares changing hands than in a normal session.

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.

A yellow pot is filled with Dianthus flowers, also known as sweet William. - Suprabhat Dutta/Getty Images ...

Dianthus Therapeutics has a 52-week low of $14.78 and a 52-week high of $32.27. The business’s 50 day moving average is $21.48 and its two-hundred day moving average is $23.91.

Dianthus Therapeutics ( NASDAQ:DNTH ) Full Year 2024 Results Key Financial Results Net loss: US$85.0m (loss widened by... Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG ...

Follow our easy guide to taking cuttings and you can create a summer display of your favourite variety of dianthus. A cottage garden favourite, pinks are easy to grow and look good at the front of ...